Key result
In a U.S. surveillance system from 2018-2023, type 1 diabetes incidence was 25.6-31.9 per 100,000 person-years in youth <18 years and 21.6-38.3 per 100,000 person-years in adults aged 18-44 years.
Why the study?
While type 1 diabetes incidence has been rising in US children over the past two decades, incidence patterns in young adults remain less known.
Observational (n=26,000,000)
Yes
The incidence of type 1 diabetes in the U.S. from 2018-2023 is higher than prior estimates for youth, with young adult-onset rates similar in magnitude.
Answers are grounded in this paper and cite their sources.
Updates U.S. T1D incidence surveillance in youth and young adults; leaves open explanations for higher rates than prior estimates.
Introduction and Objective: Incidence of type 1 diabetes (T1D) has been rising in U.S. children over the past two decades, while incidence patterns in young adults are less known. We estimated incidence of T1D in 2018-2023 among individuals aged <45 years by age group, race/ethnicity, and sex. Methods: The Diabetes in Children, Adolescents, and Young Adults (DiCAYA) Network includes six health system/networks (HS) and two population-level geographic sites, with >26 million individuals surveyed. Incident T1D was identified in electronic health records. Rates of new cases were calculated by age, sex, race/ethnicity and site type. Results: Between 2018 and 2023, 17,461 incident cases were identified among youth <18 years old. Incidence rates were 25.6 and 31.9 per 100,000 persons per year in HS and geographic sites, respectively, with variation by age, sex (in geographic sites) and race/ethnicity (Table). Rates were highest in non-Hispanic White and non-Hispanic Black, followed by Hispanic youth. In adults age 18-44 years, 28,310 cases occurred over the same period, with rates of 21.6 and 38.3 and per 100,000 persons per year in HS and geographic sites, respectively. Rates were higher in males and showed similar race/ethnicity patterns as youth. Conclusion: Youth-onset T1D incidence in 2018-2023 is higher than prior U.S. estimates from 2002-2018 and young adult-onset rates are similar in magnitude to youth-onset incidence. Disclosure T. Crume: None. A. Rajan: None. A. Bellatorre: None. R. Conway: None. M. Pavkov: None. I. Zaganjor: None. R. Anthopolos: None. J. Divers: None. S. Conderino: None. L. Thorpe: None. A.D. Liese: None. M. Mefford: Research Support; Current; Merck & Co., Inc. K. Reynolds: Research Support; Ended; Merck & Co., Inc. H. Shao: None. A.G. Hirsch: None. M. Rosenman: None. T.C. Ong: None. T.S. Hannon: None. B.S. Schwartz: None. E.M. Apperson: Speaker's Bureau; Current; Sanofi. D. Dabelea: None.
No takes yet. Share an insight, caveat, or question.
Crume et al. (2026) conducted an observational in Type 1 diabetes (n=26,000,000). Type 1 diabetes incidence surveillance was evaluated on Incident type 1 diabetes. In a U.S. surveillance system from 2018-2023, type 1 diabetes incidence was 25.6-31.9 per 100,000 person-years in youth <18 years and 21.6-38.3 per 100,000 person-years in adults aged 18-44 years.
Synapse has enriched 10 related papers. Consider them for comparative context: